Correlation Between Edesa Biotech and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and TG Therapeutics, you can compare the effects of market volatilities on Edesa Biotech and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and TG Therapeutics.

Diversification Opportunities for Edesa Biotech and TG Therapeutics

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Edesa and TGTX is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and TG Therapeutics go up and down completely randomly.

Pair Corralation between Edesa Biotech and TG Therapeutics

Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the TG Therapeutics. In addition to that, Edesa Biotech is 1.36 times more volatile than TG Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. TG Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest  2,261  in TG Therapeutics on November 2, 2024 and sell it today you would earn a total of  1,075  from holding TG Therapeutics or generate 47.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Edesa Biotech  vs.  TG Therapeutics

 Performance 
       Timeline  
Edesa Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
TG Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Edesa Biotech and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edesa Biotech and TG Therapeutics

The main advantage of trading using opposite Edesa Biotech and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Edesa Biotech and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios